Welcome to our dedicated page for Walgreen Boots SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to spot prescription-margin shifts or opioid litigation charges buried inside Walgreens Boots Alliance’s lengthy reports? The company’s global mix of U.S. pharmacy retail, Boots UK, and Alliance Healthcare distribution makes every disclosure dense and data-heavy. Stock Titan’s AI decodes each page so you don’t have to.
Open a Walgreens Boots Alliance annual report 10-K simplified and our platform pinpoints script volume trends, reimbursement rate changes, and segment profitability in seconds. Need the latest Walgreens Boots Alliance quarterly earnings report 10-Q filing? Real-time feeds pull highlights on store closures, vaccination revenue, and Village Medical partnerships as soon as they hit EDGAR.
For governance questions, the Walgreens Boots Alliance proxy statement executive compensation tab shows how pay ties to prescription growth, while Walgreens Boots Alliance insider trading Form 4 transactions reveal whether pharmacists-turned-executives are buying or selling stock. Every Walgreens Boots Alliance Form 4 insider transactions real-time alert includes AI commentary on transaction size and timing.
- AI-powered summaries translate complex accounting notes into clear language, making understanding Walgreens Boots Alliance SEC documents with AI effortless.
- All filings, always current—from sudden Walgreens Boots Alliance 8-K material events explained to shelf registrations and S-8 plans.
- Practical tools to compare quarter-over-quarter script counts, monitor cash flow swings, and flag opioid settlement reserves.
Whether you’re running an Walgreens Boots Alliance earnings report filing analysis before the bell or scanning a Walgreens Boots Alliance SEC filings explained simply overview, Stock Titan streamlines the entire research workflow. Receive alerts, read expert context, and make confident decisions—all from one page.
Silver Point Capital and two principals filed a Schedule 13G regarding Walgreens Boots Alliance (WBA). The filing states that as of August 27, 2025 the Reporting Persons beneficially owned 60,061,000 shares, representing 6.9% of 865,560,675 shares outstanding (per the issuer's June 19, 2025 count). The issuer completed a merger on August 28, 2025 and the Reporting Persons' shares were converted into the stated Per Share Consideration. The cover pages list 0 shares beneficially owned at filing, reflecting that conversion. The Schedule is jointly filed by Silver Point Capital, L.P., Edward A. Mule and Robert J. O'Shea and includes a Joint Filing Agreement.
Senior Vice President and Chief Corporate Affairs Officer Beth Amber L. Fabbri reported a disposition of 124,670 shares of Walgreens Boots Alliance, Inc. common stock on 08/28/2025. The filing shows 0 shares beneficially owned following the reported transaction. The disposal reflects cancellation of restricted stock units (including dividend-equivalent RSUs) in connection with the merger described in the filing: at the merger's effective time each share of common stock was converted into $11.45 in cash plus one divested asset proceed right. The filing notes that consideration for any RSUs that were unvested at the effective time remains subject to continued employment-based vesting conditions.
Manmohan Mahajan, EVP and Global CFO of Walgreens Boots Alliance (WBA), reported a transaction dated 08/28/2025 disposing of 414,273 shares of WBA common stock, leaving him with 0 shares beneficially owned following the transaction. The Form 4 explains the disposition resulted from the Merger under the March 6, 2025 Merger Agreement, where each share was converted at the Effective Time into $11.45 in cash plus one Divested Asset Proceed Right. RSUs held by the reporting person were cancelled in exchange for the Per Share Consideration, although any unvested RSUs remain subject to the original vesting conditions tied to continued service.
Lanesha Minnix, EVP, Global CLO & Corporate Secretary of Walgreens Boots Alliance (WBA), reported the automatic disposition of 348,093 shares of WBA common stock on 08/28/2025 as a result of the closing of a merger. Under the Merger Agreement, each WBA share converted into $11.45 cash per share plus one divested asset proceed right. All RSUs held by the reporting person were cancelled and exchanged for the per-share consideration; payment for any unvested RSUs remains subject to the holder’s continued employment and prior vesting conditions. Following the transaction the reporting person beneficially owns 0 shares of WBA common stock.
FAQ
What is the current stock price of Walgreen Boots (WBA)?
What is the market cap of Walgreen Boots (WBA)?
